A long-term fulvestrant eluting implant is safe, non-toxic, and reduces the risk of breast cancer in in vivo models

For individuals at high risk of developing breast cancer, interventions to mitigate this risk include surgical removal of their breasts and ovaries or five years treatment with the anti-estrogen tamoxifen or aromatase inhibitors. We hypothesized that a silicone based anti-estrogen-eluting implant pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Scott, Roche, Elysia, Desai, Pujan, Pawlowska, Nela, Bauer, Diana, Gingrich, David, Hsu, Emily, Deitchman, Amelia N., Aweeka, Fran, Munster, Pamela N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635313/
https://www.ncbi.nlm.nih.gov/pubmed/37961240
http://dx.doi.org/10.21203/rs.3.rs-3459372/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635313/
https://www.ncbi.nlm.nih.gov/pubmed/37961240
http://dx.doi.org/10.21203/rs.3.rs-3459372/v1

Ejemplares similares